SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is experiencing extreme volatility following a major revenue-generating data center lease agreement, with the community sharply divided between bulls celebrating the deal as a transformative infrastructure pivot and bears accusing the company of stock manipulation and deceptive reporting. Investors remain highly focused on the company's ability to execute these long-term contracts while navigating concerns over dilution and historical price action.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic shift into AI infrastructure following its acquisition of Northern Data and the deployment of Quake AI. The community is actively debating the potential for a short squeeze fueled by record-high short interest and high trading volume, while awaiting formal guidance on the company's ability to monetize its expanded GPU and data center capacity.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as investors brace for a critical earnings report, with the community actively debating whether the company can convert its massive $60B+ order backlog into sustainable profit margins. While bears point to governance concerns and legal overhangs, bulls are betting that strong execution and infrastructure demand will force a significant repricing of the stock.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is seeing heightened volatility and a sharp sell-off as investors react to a marginal revenue miss and revised growth expectations, overshadowing the company's strong profitability and share repurchase activity. While some community members are liquidating positions in fear of further downside, others are viewing the pullback as a prime 'loading zone' for a long-term recovery, citing robust fundamentals and an attractive forward valuation.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp (QMCO) is trending as retail investors debate the stock's future amid a significant price rally, ongoing concerns over its financial stability, and confusion regarding its exposure to the quantum computing sector. Community sentiment is deeply polarized, with bulls highlighting the stock's potential for momentum-driven short squeezes and AI-related storage demand, while bears point to heavy debt, earnings volatility, and potential regulatory scrutiny.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors show renewed interest in its strategic pivot toward AI data center infrastructure and defense technology, fueled by developments in its Neural I/O initiative and joint ventures. Community members are actively discussing potential partnerships with major semiconductor companies and the company's progress in MicroLED technology, often citing management's guidance on future growth as a catalyst for long-term optimism.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to strong earnings results, a surge in backlog, and a massive 1GW steam turbine contract with Siemens Energy aimed at fueling AI data center power demand. The community is actively debating the company's long-term potential as a critical infrastructure play, with many bullish on its growth pipeline while others weigh the risks of high short interest and institutional price volatility.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is experiencing significant volatility following a major leadership restructuring, with co-founders stepping back into CEO roles to drive the next phase of growth. The market remains divided between those viewing the management shake-up as a signal of internal challenges and others who see it as a strategic move to refocus on product innovation and premium brand integrity.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock remains a primary focus for the community as investors weigh the impact of recent analyst downgrades against hopes for a long-term turnaround strategy in China. While many are frustrated by the stock's persistent downtrend and recent volatility, a vocal base of investors is using the current price levels to average down, betting on the strength of the brand and potential dividend-driven value.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors await Q1 earnings, with community sentiment high regarding the growth of its RECORLEV franchise and the upcoming Phase 3 initiation for the once-weekly injectable levothyroxine candidate, XP-8121. Despite recent share price volatility, discussion is focused on the company's trajectory toward sustained profitability, improved margins, and the potential for a significant valuation rerating as clinical milestones approach.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher?

Key PointsIovance's revenue rose 66% last quarter due to strong demand for Amtagvi...

Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect?

The mean of analysts' price targets for Iovance Biotherapeutics (IOVA) points to a 28% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

IOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake

Iovance rises 43% after Q2 results top estimates as Amtagvi sales beat forecasts, boosting revenues and prompting a review of full-year guidance.

Why Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today?

Equity

The rally showed that investors are paying more attention to fast-growing healthcare and digital media companies. 


Why S&P 500, Dow Futures Are Slipping Overnight After Wall Street’s Second Straight Day In The Red 

WTI crude crossed $78 as uncertainty over an Iran-Oman shipping agreement fueled inflation concerns.

Iovance (IOVA) Stock Soars After Better-Than-Expected Q2 Results

Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares are surging Thursday after the cancer therapy company shattered second-quarter expectations on both the top and bottom lines. Here's what you should know.read more...

Catalysts Put These Companies in the Spotlight

ClearOne (NASDAQ CLRO), NeOnc Technologies (NASDAQ:NTHI), Iovance Biotherapeutics (NASDAQ:IOVA), and Ensysce Biosciences (NASDAQ:ENSC) are covered in today’s roundup.

IOVA Stock Heads For Best Day In Over 6 Years – Buyout Buzz Builds After Blowout Q2

The biotech company reported record second-quarter revenue fueled by strong sales of its cancer therapy Amtagvi.


Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of +35.29% and +13.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas (ARVN) delivered earnings and revenue surprises of +1,175.00% and +562.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Anticipation is building for the upcoming LUN-202 lung cancer data, with investors viewing this readout as a primary value driver.

Heightened speculation persists regarding a massive short squeeze as over 100 million shares remain shorted against tightening fundamentals.

Persistent chatter continues about the potential for a premium acquisition by Big Pharma given the platform's multi-indication addressable market.

Strong Q2 performance, operational discipline, and expanded manufacturing efficiencies are reinforcing the company's clear path to future profitability.

The company's extensive portfolio of over 1,000 global patents creates a significant defensive barrier protecting its unique TIL therapy platform.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IOVAIovance Biotherapeutics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest IOVA News